RxDoctor Payments Data

Rachel Messer

Family · Birmingham, ALNPI 1447640628

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 1,149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,874in general payments, 2019–2025

Across 1,149 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Pfizer$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Johnson & Johnson$1K
  • AstraZeneca$1K
  • Incyte Corporation$1K
  • plus $14K from 54 others

What the payments were for

  • Food & beverage$21,42698%
  • Education$4482%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis131$2,096
Pfizer79$1,406
E.r. Squibb & Sons, L.L.C.76$1,304
Johnson & Johnson53$1,151
AstraZeneca(2 entities)56$1,066
Incyte Corporation40$1,035
Takeda Pharmaceuticals U.S.A., Inc.37$796
Bristol Myers Squibb43$777
Seagen Inc.38$712
Amgen32$663
Eisai Inc.34$658
AbbVie31$610
Lilly USA, LLC36$596
CSL Behring18$591
Sanofi25$509
Merck27$496
Daiichi Sankyo Inc.19$388
Gilead(2 entities)23$383
Pharmacosmos Therapeutics Inc.13$359
GSK21$358
Beigene USA, Inc.21$353
Deciphera Pharmaceuticals Inc.20$350
Bayer17$338
Regeneron Healthcare Solutions, Inc.15$296
Stemline Therapeutics Inc.13$272
Jazz Pharmaceuticals Inc.14$261
Genentech USA, Inc.14$255
Servier Pharmaceuticals LLC13$241
Blueprint Medicines Corporation10$221
Sobi, Inc10$206
Karyopharm Therapeutics Inc.11$197
Pharmacyclics LLC, An Abbvie Company12$195
Ipsen Biopharmaceuticals, Inc8$179
Astellas Pharma US Inc10$168
Array Biopharma Inc9$159
Rigel Pharmaceuticals, Inc.7$130
Morphosys, US Inc.7$124
Puma Biotechnology, Inc.7$122
Pharmaessentia USA Corporation6$111
Beone Medicines USA, Inc.6$107
Acrotech Biopharma Inc.6$106
Boehringer Ingelheim4$106
Sumitomo Pharma America, Inc.4$88
Spectrum Pharmaceuticals Inc.4$88
ADC Therapeutics America, Inc.5$87
Taiho Oncology, Inc.5$86
AVEO Pharmaceuticals, Inc.5$84
Exelixis Inc.5$82
Progenics Pharmaceuticals, Inc.4$80
Recordati_rare_diseases_inc.4$77
Tempus AI, Inc2$54
Agios Pharmaceuticals, Inc.3$53
EMD Serono, Inc.3$48
Myovant Sciences Inc.3$48
Shield Therapeutics Inc3$47
Global Blood Therapeutics, Inc.3$46
HEMA Biologics, LLC2$42
Coherus Oncology, Inc.2$41
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$40
Epizyme, Inc.2$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,874 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$7,851
Medicare patients
48
Services billed
102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →